Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Malaz Abutarif, PhD
Vice President, Global Head of Quantitative Clinical Pharmacology
Daiichi Sankyo Inc
Poster(s):
171: Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase 1 Study
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT